Simran
Simran is pursuing a combined MD/PhD in the Harvard-MIT MD program and Immunology PhD program. Previously, she was a research technician at Fred Hutch, where she helped design novel protein-based cancer therapeutics and a SARS-CoV-2 vaccine.
Helena
Helena studied at Columbia and NYU. She has served as a Contributing Editor and Senior Contributor at The New Inquiry, and her work has been excerpted or cited in The Atlantic, Harper's, and The New York Times, among others.
Jonathan
Jonathan is an MPA student at Columbia University School of International and Public Affairs. He earned his Bachelor's from Tufts University, where he double-majored in Politcal Science and Economics.